Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dimaio F < Dimitrov D < Dinesh K

Dimiter S. Dimitrov
Center for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, PA 15261, USA. dsd116@pitt.edu.
000376
Protein Interactions Group, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702-12011; dimiter.dimitrov@nih.gov shibojiang@fudan.edu.cn.
001486
Protein Interactions Group, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA yingt@mail.nih.gov dimiter.dimitrov@nih.gov.
001992
Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland.
001224
Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
000F98
001772
Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA. dimitrdi@mail.nih.gov.
000A79
Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.
000D27
Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA.
001467
Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland.
001538

<g>
<k>Dimitrov D</k>
<l>
<g>
<k>Dimiter S. Dimitrov</k>
<l>
<g>
<k>
<nlm:affiliation>Center for Antibody Therapeutics, University of Pittsburgh Medical School, Pittsburgh, PA 15261, USA. dsd116@pitt.edu.</nlm:affiliation>
</k>
<l>
<i>000376</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Protein Interactions Group, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702-12011; dimiter.dimitrov@nih.gov shibojiang@fudan.edu.cn.</nlm:affiliation>
</k>
<l>
<i>001486</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Protein Interactions Group, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland, USA yingt@mail.nih.gov dimiter.dimitrov@nih.gov.</nlm:affiliation>
</k>
<l>
<i>001992</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, NIH, Frederick, Maryland.</nlm:affiliation>
</k>
<l>
<i>001224</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.</nlm:affiliation>
</k>
<l>
<i>000F98</i>
<i>001772</i>
</l>
<n>2</n>
<t>2</t>
</g>
<g>
<k>
<nlm:affiliation>Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, 21702, USA. dimitrdi@mail.nih.gov.</nlm:affiliation>
</k>
<l>
<i>000A79</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD, USA.</nlm:affiliation>
</k>
<l>
<i>000D27</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland 21702, USA.</nlm:affiliation>
</k>
<l>
<i>001467</i>
</l>
<n>1</n>
<t>1</t>
</g>
<g>
<k>
<nlm:affiliation>Protein Interactions Section, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, Maryland.</nlm:affiliation>
</k>
<l>
<i>001538</i>
</l>
<n>1</n>
<t>1</t>
</g>
</l>
<n>9</n>
<t>10</t>
</g>
</l>
<n>1</n>
<t>10</t>
</g>

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021